Emerging evidence indicates that FOXO3 acts as a tumor suppressor in cancer: FOXO3 is commonly inactivated in cancer cell lines either by cytoplasmic sequestration of FOXO3 protein or by mutation of the FOXO3 gene [29]. This evidence concerns the gene FOXO3 and cancer.